READ OUR NEW PRESS RELEASE!!  NEW VALIDATION DATA OF HER2DX®️ IN THE PerELISA TRIAL
CONVERSATIONS WITH EXPERTS
September 23rd, 4:30 p.m. (CEST)
REGISTER HERE

Redefining precision oncology

Unlocking the full potential of patient information

We want to change how biomarkers are routinely used in oncology

Separator

Analyze
the Past

Analyzing
complex genomic
and clinical data

Separator

Decode
the present

Decoding biomarkers before,
during or after therapies
using different biopsy-based approaches

Separator

Reveal
the future

Revealing innovative tests of
high analytical complexity,
but easy-to-interpret results